Deferral of maternal isoniazid preventive therapy to early postpartum had no effect on infant tuberculosis acquisition in our trial population, regardless of the diagnostic test used.
Dr. Vidya Mave and colleagues concluded considerable intrahost mycobacterium tuberculosis mutation rates were present at recurrence among patients with diabetes mellitus.
Dr. Akshay Gupte and team found females were 7 times more likely to have restrictive spirometry pattern and 22 times more likely to have preserved ratio impaired spirometry, compared with men.
BJGMC-JHU Clinical Research Site (CRS) in Pune hosted 400+ engaging panel discussions, interactive outreach programs, and impactful awareness campaigns for World TB Day 2024.
The study ‘One to Three’ will compare the treatment completion of daily dose of Rifapentine and Isoniazid for a month (1HP) to the weekly dose of Rifapentine and Isoniazid for three months (3HP) in persons living with HIV in Pune.
For World AIDS Day, BJGMC CRS), Pune, hosted a discussion on six major HIV related studies.
The Improved Management with Antimicrobial Agents Isoniazid Rifampicin Linezolid for TBM (IMAGINE-TBM) trial will compare a six-month regimen of four drugs with the nine-month, standard-of-care regimen for TBM.
Check out the photo gallery from CIDI at the 2023 Union Conference on Lung Health.
CIDI was in Paris for The Union Conference on Lung Health 2023! Check out what CIDI faculty and Johns Hopkins India Partners spoke about at the sessions listed!